momenta pharmaceuticals inc
Earnings & Estimates Summary - MOMENTA PHARMACEUTICALS INC (MNTA)
2013 revenues at Momenta Pharmaceuticals Inc. totaled $35.5M USD, while annual losses equaled $2.13 per share.
Quarterly Earnings & Estimates - MOMENTA PHARMACEUTICALS INC (MNTA)
Momenta Pharmaceuticals Inc.'s Quarterly Earnings
Momenta Pharmaceuticals Inc. reported 2nd quarter 2014 on 08/2/2014.
Annual Earnings & Estimates - MOMENTA PHARMACEUTICALS INC (MNTA)
Momenta Pharmaceuticals Inc.'s Annual Earnings
Momenta Pharmaceuticals Inc. reported annual 2013 losses of $2.13 per share on 02/12/2014.
Quarterly Revenues - MOMENTA PHARMACEUTICALS INC (MNTA)
Annual Revenues - MOMENTA PHARMACEUTICALS INC (MNTA)
Momenta Pharmaceuticals Inc.'s Annual Revenues
Momenta Pharmaceuticals Inc. had revenues for the full year 2013 of $35.5M USD. This was -44.5% below the prior year's results.
|Amarin Corp PLC||$2.26 USD||+0.06|
|Amphastar Pharmaceuticals Inc||$16.26 USD||+0.51|
|OraSure Technologies Inc||$4.94 USD||-0.12|
|SciClone Pharmaceuticals Inc||$9.11 USD||-0.10|
|Sucampo Pharmaceuticals Inc||$21.79 USD||+0.89|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|